Abstract Submission


Track Descriptions

The Biomedical Engineering Society (BMES) and the US Food and Drug Administration (FDA) have partnered to co-sponsor the BMES/FDA Frontiers in Medical Devices Conference: Advancing Translational Science. This conference will provide a forum for participants involved in the development and evaluation of medical devices to meet and share their expertise, establish collaborations, and discuss strategies to effectively utilize computational modeling to support patient care and improve final outcomes. The conference will take place May 16-18, 2017, at the College Park Marriott Hotel and Conference Center at the University of Maryland, College Park, MD (Washington, DC Metropolitan Area).

Technical tracks will focus on different stages of the product development process and will be chaired by an international panel of lead researchers and modelers from industry, government and academia. Top student submissions across tracks will be highlighted in a student paper competition.

Natalie Artzi, PhD (Massachusetts Institute of Technology)
Mercedes Balcels, PhD (Massachusetts Institute of Technology)
Andrew Drach, PhD (U.T. Austin)
Chris Scully, PhD (U.S. Food and Drug Administration)
Linda Knudsen (Syncroness, Inc.)
Product development
Sudeep Sastry, PhD (W.L. Gore)
Socrates Dokos, (Univ. of New South Wales, Australia)
Clinical study
Pras Pathmanathan, PhD (U.S. Food and Drug Administration)
Mehul Dharia (Zimmer Biomet)
Market release and post-market
Finn Donaldson, PhD (U.S. Food and Drug Administration)
Mark Palmer, MD, PhD (Medtronic)

Abstracts are now being solicited that highlight the latest developments in computer methods and best practices in computational modeling and simulation of medical devices. Deadline for submission is January 22, 2017.